Regulatory proteins that bind to upstream un-translated region often control transcription of prokaryotic genes. Many of these proteins bend or distort their DNA binding sites, and the induced DNA curvature facilitates protein-protein or protein-DNA contacts essential for transcriptional regulation. DnrO is an essential transcription regulator of Streptomyces peucetius that activates daunorubicin biosynthetic pathway. It binds to a specific sequence adjacent to dnrN promoter to activate transcription. The same binding event represses its own transcription. DNA binding domain of DnrO is within 60 aa from N-terminal end of the 340 aa protein. Helix-turn-helix motif in DnrO is similar to BirA repressor of E. coli. In this study, we show that this dual functional protein does not cause any localized bending of DNA as observed by circular permutation gel shift assay. This observation complements the functional role of DnrO as an activator/repressor, since the change in DNA topology might impede the activation or repression function if this protein. This is in variance with DNA bending property of BirA repressor and many other transcription factors. The possibility of G+C rich sequences in the target DNA not favoring distortion of major groove upon protein binding is discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2010.01.019 | DOI Listing |
AMB Express
June 2024
National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai, 201203, P. R. China.
Int J Syst Evol Microbiol
May 2024
Key Laboratory of Southwest China Wildlife Resources Conservation (Ministry of Education), College of Life Science, China West Normal University, Nanchong 637009, Sichuan Province, PR China.
A novel actinobacterium, designated strain CWNU-1, was isolated from the rhizospheric soil of D. Don and examined using a polyphasic taxonomic approach. The organism developed pale blue aerial mycelia that was simply branched and terminated in open or closed coils of three or more volutions on International Project 3 agar.
View Article and Find Full Text PDFAMB Express
April 2024
National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai, 201203, P. R. China.
Doxorubicin is an important class of anthracycline antitumor antibiotics produced by Streptomyces peucetius. The doxorubicin fermentation yield of the wild-type strain was very low, so it could not be produced directly by fermentation at an industrial scale due to the high cost. In the present study, S.
View Article and Find Full Text PDFFront Bioeng Biotechnol
February 2024
Institute of Biology, Leiden University, Leiden, Netherlands.
Daunorubicin and doxorubicin, two anthracycline polyketides produced by , are potent anticancer agents that are widely used in chemotherapy, despite severe side effects. Recent advances have highlighted the potential of producing improved derivatives with reduced side effects by incorporating l-rhodosamine, the -dimethyl analogue of the native amino sugar moiety. In this study, we aimed to produce -dimethylated anthracyclines by engineering the doxorubicin biosynthetic pathway in the industrial strain G001.
View Article and Find Full Text PDFAppl Microbiol Biotechnol
December 2024
Department of Life Science and Biochemical Engineering, Sun Moon University, 70 Sun Moon-Ro 221, Tangjeong-Myeon, Asan-Si, 31460, Chungnam, Korea.
Streptomyces peucetius ATCC 27952 is known to produce a variety of secondary metabolites, including two important antitumor anthracyclines: daunorubicin and doxorubicin. Identification of peucemycin and 25-hydroxy peucemycin (peucemycin A), as well as their biosynthetic pathway, has expanded its biosynthetic potential. In this study, we isolated a new peucemycin derivative and identified it as 19-hydroxy peucemycin (peucemycin B).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!